{
    "title": "PTC Therapeutics to buy expensive DMD drug, signals price change",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-4319956/Marathon-Pharma-sell-Duchenne-drug-PTC-Therapeutics.html",
    "date": "2017-03-16",
    "keywords": [
        "price",
        "drug",
        "emflaza",
        "dmd",
        "steroid",
        "tag",
        "percent",
        "deflazacort",
        "approval",
        "ptc",
        "peltz",
        "marathon",
        "fda",
        "grovermarch",
        "thursday",
        "dystrophy",
        "afternoon",
        "disorder",
        "muscle",
        "deterioration",
        "age",
        "class",
        "conditionsmarathon",
        "option",
        "februarymarathon",
        "criticism",
        "change",
        "level",
        "executive",
        "stuart",
        "conference",
        "call",
        "thursdayeven",
        "onefourth",
        "onefifth",
        "acquisition",
        "analyst",
        "christopher",
        "marai",
        "saidptc",
        "cash",
        "stock",
        "stake",
        "deal",
        "translarna",
        "saidtranslarna",
        "subset",
        "europe",
        "year",
        "decision",
        "inflammation",
        "activity",
        "prednisone",
        "diseasemodifying",
        "treatment",
        "data",
        "market",
        "exclusivity",
        "researchthe",
        "resistance",
        "reporting",
        "grover",
        "bengaluru",
        "editing",
        "dsouza",
        "shounak",
        "dasgupta"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}